Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 608-271-2 | CAS number: 28861-00-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1990-1991
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: Dust in air concentration determination is not reliable. Exact animal exposure can not be determined.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Principles of method if other than guideline:
- Deviation from guideline: granulometry was not determined from the sample powder. Dust concentration in air was not measured by an approriate analitical method.
- GLP compliance:
- no
- Test type:
- other: acute inhalation toxicity sudy
- Limit test:
- yes
Test material
- Reference substance name:
- Tyrosine, N-(aminocarbonyl)-3-methoxy-O,α-dimethyl-
- EC Number:
- 608-271-2
- Cas Number:
- 28861-00-9
- Molecular formula:
- C13H18N2O5
- IUPAC Name:
- Tyrosine, N-(aminocarbonyl)-3-methoxy-O,α-dimethyl-
- Details on test material:
- Name of test material (as cited in study report): Ureido-karbonsav
- Substance type: organic
- Physical state: white crystalline powder
- Stability under test conditions: stable
- Storage condition of test material: room temperature
- Other: sparingly soluble in water
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:
- Age at study initiation:
- Weight at study initiation:
- Fasting period before study: 12h
- Housing: 5-5 animals/cages
- Diet (e.g. ad libitum): LATI
- Water (e.g. ad libitum): ad libitum
- Acclimation period:
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-22
- Humidity (%): 40-70
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): 12h/12 h
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- clean air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus:
- Exposure chamber volume: 0.3 m3
- Method of holding animals in test chamber: connecting to glass tubes in a 40 cm wall
- Source and rate of air:
- Method of conditioning air:
- System of generating particulates/aerosols:
- Method of particle size determination:
- Treatment of exhaust air:
- Temperature, humidity, pressure in air chamber:
TEST ATMOSPHERE
- Brief description of analytical method used: calculation
- Samples taken from breathing zone: yes/no
VEHICLE
- Composition of vehicle (if applicable): DMSO
- Concentration of test material in vehicle (if applicable):
- Justification of choice of vehicle:
- Lot/batch no. (if required):
- Purity:
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: not determined
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): not determined
CLASS METHOD (if applicable)
- Rationale for the selection of the starting concentration: - Analytical verification of test atmosphere concentrations:
- no
- Remarks:
- only calculation
- Duration of exposure:
- 4 h
- Concentrations:
- ALC
29.2 mg/m3;
84.4 mg/m3;
136.7 mg/m3;
LC50
27.7 mg/m3;
83.3 mg/m3;
133.8 mg/m3 - No. of animals per sex per dose:
- 10 males/10 females
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 0; 1; 2; 3; 4; 7; 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, relative organ weights, histopathology
Results and discussion
- Mortality:
- No.
- Clinical signs:
- other: No.
- Body weight:
- Body weight gain of treated animals was smaller, than the untreated animals.
- Gross pathology:
- Slight changes in lungs.
Treated females liver and kidney relative organ weight was decreased.
Any other information on results incl. tables
Body weight change after treatment in gramm (g)
Males (average value, n = 10)
Dose (mg/m3) | 0 | 1 day | 2 day | 3 day | 4 day | 7 day | 14 day | Body weight increase (g) |
133.8 | 245.0 +/-16.0 | 255.0 +/-13.0 | 270.6 +/- 13.7 | 275.0 +/- 13.0 | 276.0 +/- 8.4 | 293.7 +/- 13.0 | 300.6 +/- 11.4 | +55.6 |
83.3 | 247.5 +/-26.9 | 247.5 +/-23.7 | 252.5 +/- 26.3 | 263.7 +/-15.4 | 278.1 +/- 24.0 | 294.3 +/- 24.1 | 300.6 +/- 24.7 | +53.1 |
27.7 | 245.0 +/-16.4 | 243.1 +/-14.6 | 248.1 +/- 14.6 | 252.5 +/- 15.5 | 261.8 +/- 13.8 | 280.0 +/- 16.6 | 301.2 +/- 15.7 | +56.2 |
Control | 242.5 +/- 10.0 | 236.8 +/- 10.9 | 241.8 +/-10.3 | 254.3 +/- 11.7 | 259.3 +/- 12.0 | 288.7 +/- 12.4 | 303.1 +/- 13.6 | +60.6 |
Control (untreated) | 241.7 +/- 14.2 | 243.7 +/- 16.4 | 254.2 +/- 14.2 | 258.9 +/- 12.7 | 270.2 +/- 14.6 | 281.4 +/- 16.2 | 303.0 +/- 14.2 | +61.3 |
Females (average value, n =10)
Dose (mg/m3) | 0 | 1 day | 2 day | 3 day | 4 day | 7 day | 14 day | Body weight increase (g) |
133.8 | 199.3 +/-12.0 | 196.8 +/-13.8 | 208.9 +/- 14.8 | 208.1+/- 13.3 | 212.5 +/- 13.3 | 223.7 +/- 15.0 | 234.3 +/- 13.9 | +35.0 |
83.3 | 187.5 +/-11.0 | 187.5 +/-12.8 | 186.6 +/- 12.2 | 185.6 +/-12.0 | 185.6 +/- 11.1 | 202.5 +/- 18.3 | 219.3 +/- 15.9 | +31.2 |
27.7 | 188.1 +/-13.8 | 188.1 +/-13.8 | 191.8 +/- 14.3 | 198.7 +/- 13.8 | 201.8 +/- 12.7 | 219.3 +/- 13.7 | 227.5 +/- 12.2 | +39.3 |
Control | 194.3 +/- 15.6 | 201.8 +/- 11.3 | 201.8 +/-14.1 | 201.8 +/- 16.0 | 203.1 +/- 17.1 | 223.7 +/- 20.4 | 234.3 +/- 17.4 | +40.0 |
Control (untreated) | 192.4+/- 12.4 | 193.2 +/- 14.2 | 198.3 +/- 12.7 | 206.4 +/- 14.6 | 214.3 +/- 13.7 | 226.4 +/- 16.2 | 233.7 +/- 14.2 | +41.3 |
Relative organ weight (100 g body weight) of male rats (average, n= 10)
Dose (mg/m3) | Brain | Liver | Kidney | Lung | Heart | Spleen | Thymus | Adrenal |
133.8 | 0.51 +/-0.06 | 3.66 +/- 0.71 | 0.65 +/- 0.08 | 0.52 +/- 0.04 | 0.27 +/- 0.04 | 0.21 +/- 0.04 | 0.14 +/- 0.05 | 0.01 +/- 0.003 |
83.3 | 0.54 +/- 0.06 | 3.57 +/- 0.74 | 0.68 +/- 0.12 | 0.52 +/- 0.05 | 0.27 +/- 0.05 | 0.22 +/- 0.06 | 0.16 +/- 0.03 | 0.01 +/- 0.001 |
27.7 | 0.56 +/-0.04 | 3.68 +/- 0.36 | 0.64 +/- 0.03 | 0.52 +/-0.06 | 0.26 +/- 0.03 | 0.21 +/- 0.02 | 0.14 +/- 0.02 | 0.01 +/- 0.001 |
Control | 0.62 +/-0.04 | 4.01 +/- 0.26 | 0.72 +/-0.02 | 0.51 +/-0.04 | 0.28 +/-0.01 | 0.26 +/-0.02 | 0.22 +/-0.03 | 0.002 +/-0.002 |
Control (untreated) | 0.61 +/-0.05 | 4.05 +/- 0.19 | 0.72 +/-0.04 | 0.50 +/-0.03 | 0.28 +/-0.01 | 0.23 +/-0.02 | 0.17 +/-0.02 | 0.01 +/-0.001 |
Relative organ weight (100 g body weight) of female rats (average, n= 10)
Dose (mg/m3) | Brain | Liver | Kidney | Lung | Heart | Spleen | Thymus | Adrenal |
133.8 | 0.61 +/-0.05 | 3.43 +/- 0.61 | 0.60 +/- 0.10 | 0.56 +/- 0.09 | 0.34 +/- 0.05 | 0.32 +/- 0.09 | 0.15 +/- 0.04 | 0.02 +/- 0.003 |
83.3 | 0.68 +/- 0.19 | 3.18 +/- 1.08 | 0.70+/- 0.05 | 0.67 +/- 0.15 | 0.31 +/- 0.06 | 0.24 +/- 0.05 | 0.16 +/- 0.06 | 0.03 +/- 0.001 |
27.7 | 0.63 +/-0.06 | 3.96 +/- 0.32 | 0.61 +/- 0.03 | 0.54 +/-0.05 | 0.29 +/- 0.02 | 0.24 +/- 0.03 | 0.13 +/- 0.02 | 0.03 +/- 0.001 |
Control | 0.65 +/-0.06 | 4.15 +/- 0.45 | 0.68 +/-0.04 | 0.53 +/-0.06 | 0.28 +/-0.02 | 0.25 +/-0.04 | 0.20 +/-0.05 | 0.002 +/-0.001 |
Control (untreated) | 0.66 +/-0.05 | 4.12 +/- 0.36 | 0.67 +/-0.04 | 0.52 +/-0.05 | 0.28 +/-0.02 | 0.23 +/-0.04 | 0.17 +/-0.03 | 0.01 +/-0.001 |
Applicant's summary and conclusion
- Interpretation of results:
- other: toxic effects can not be excluded
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The inhalation acute toxicity was not determined, because of analitycal problems of the test materials.
According to the observation of the animal studies inhalation toxicity can not be excluded.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.